Daily Study

A lower session: SPY −0.49%, QQQ −1.35%

Three screens filtered 1,926 US stocks down to 12 names on this page: the top and the bottom of each ordering. 8 of 12 closed lower and 4 higher; small caps (IWM) moved −0.06%.

SPY−0.49%
S&P 500 ETF752.04
QQQ−1.35%
Nasdaq 100 ETF681.22
IWM−0.06%
Russell 2000 ETF279.20
DIA+0.44%
Dow 30 ETF519.29
names screened
1,926
studied in depth
141
on this page
12
screens
3

A record of what moved, not a recommendation.Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRLMethodologyDisclaimer

Each screen starts from a broad filter of US stocks; the candidates are then ordered by a combined fundamentals-and-trend read. The page shows the names at the top and at the bottom of that order, so you see both ends of the same filter, not a pick list. Open any case study for the session, the three-month trend and the latest SEC financials. IEX volume is only the share traded on IEX, so it is compared with its own 20-day average.

Learn more: Top and Bottom of the Screen: An Ordering, Not a Verdict · Where the Numbers Come From: IEX Prices and SEC Filings

534matched the screen
60studied in depth
4on this page

Top of the screen

SWIM

Latham Group Inc

7.46+1.8%
IndustrialsBuilding Products & Equipment
3 months+2.1%
52-week range52w low67%high
RSI (14)77
Session
below VWAP 7.511.68× avg vol
Moving averages
above 50dabove 200d
View SWIM chart on TradingView Affiliate
Case study: why SWIM is on this page

Landed at the top of today's combined fundamentals-and-trend screen for this group: reported a net profit in its latest fiscal year; annual revenue grew 7% year over year; price sits above its 200-day average.

Close 7.46: +1.8% vs previous closeSession (open→close): +0.3%

Session: day range 7.40–7.64, VWAP 7.51 (below VWAP), IEX volume 1.68× its 20-day average. Trend: +2.1% over three months, 67% of the way up its 52-week range, RSI(14) 77, above its 50-day and above its 200-day average.

Intraday chart of SWIM on 2026-11-02
Session (intraday)
Three-month daily chart of SWIM
Three months (daily)
Revenue (latest FY)
$545.9M
Net income (latest FY)
$11.1M
Cash
$43.5M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Latham Group Inc filings on SEC EDGAR

MNTK

Montauk Renewables Inc

2.41+9.0%
Basic MaterialsSpecialty Chemicals
3 months+42.6%
52-week range52w low60%high
RSI (14)54
Session
above VWAP 2.380.74× avg vol
Moving averages
above 50dabove 200d
View MNTK chart on TradingView Affiliate
Case study: why MNTK is on this page

Landed at the top of today's combined fundamentals-and-trend screen for this group: reported a net profit in its latest fiscal year; annual revenue grew 0% year over year; price sits above its 200-day average; moved +42.6% over the last three months.

Close 2.41: +9.0% vs previous closeSession (open→close): +7.6%

Session: day range 2.24–2.42, VWAP 2.38 (above VWAP), IEX volume 0.74× its 20-day average. Trend: +42.6% over three months, 60% of the way up its 52-week range, RSI(14) 54, above its 50-day and above its 200-day average.

Intraday chart of MNTK on 2026-11-02
Session (intraday)
Three-month daily chart of MNTK
Three months (daily)
Revenue (latest FY)
$176.4M
Net income (latest FY)
$1.7M
Cash
$15.8M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Montauk Renewables Inc filings on SEC EDGAR

Bottom of the screen

PROK

ProKidney Corp

1.12−13.5%
HealthcareBiotechnology
3 months−32.9%
52-week range52w low11%high
RSI (14)30
Session
above VWAP 1.013.81× avg vol
Moving averages
below 50dbelow 200d
View PROK chart on TradingView Affiliate
Case study: why PROK is on this page

Landed at the bottom of today's combined fundamentals-and-trend screen for this group: reported a net loss in its latest fiscal year; annual revenue grew 1075% year over year; price sits below its 200-day average; moved -32.9% over the last three months.

Close 1.12: −13.5% vs previous closeSession (open→close): −15.8%

Session: day range 0.88–1.33, VWAP 1.01 (above VWAP), IEX volume 3.81× its 20-day average. Trend: −32.9% over three months, 11% of the way up its 52-week range, RSI(14) 30, below its 50-day and below its 200-day average.

Intraday chart of PROK on 2026-11-02
Session (intraday)
Three-month daily chart of PROK
Three months (daily)
Revenue (latest FY)
$893.0K
Net income (latest FY)
−$69.0M
Cash
$74.9M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: ProKidney Corp filings on SEC EDGAR

ARTV

Artiva Biotherapeutics Inc

4.18−0.1%
HealthcareBiotechnology
3 months−63.5%
52-week range52w low10%high
RSI (14)21
Session
at VWAP 4.181.48× avg vol
Moving averages
below 50dbelow 200d
View ARTV chart on TradingView Affiliate
Case study: why ARTV is on this page

Landed at the bottom of today's combined fundamentals-and-trend screen for this group: reported a net loss in its latest fiscal year; annual revenue shrank 100% year over year; price sits below its 200-day average; moved -63.5% over the last three months.

Close 4.18: −0.1% vs previous closeSession (open→close): −0.2%

Session: day range 4.14–4.22, VWAP 4.18 (at VWAP), IEX volume 1.48× its 20-day average. Trend: −63.5% over three months, 10% of the way up its 52-week range, RSI(14) 21, below its 50-day and below its 200-day average.

Intraday chart of ARTV on 2026-11-02
Session (intraday)
Three-month daily chart of ARTV
Three months (daily)
Revenue (latest FY)
$0
Net income (latest FY)
−$83.9M
Cash
$301.5M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Artiva Biotherapeutics Inc filings on SEC EDGAR

1,371matched the screen
60studied in depth
4on this page

Top of the screen

GEN

Gen Digital Inc

29.89+2.5%
TechnologySoftware - Infrastructure
3 months+6.9%
52-week range52w low87%high
RSI (14)73
Session
below VWAP 30.091.20× avg vol
Moving averages
above 50dabove 200d
View GEN chart on TradingView Affiliate
Case study: why GEN is on this page

Landed at the top of today's combined fundamentals-and-trend screen for this group: reported a net profit in its latest fiscal year; annual revenue grew 27% year over year; price sits above its 200-day average.

Close 29.89: +2.5% vs previous closeSession (open→close): +2.4%

Session: day range 29.02–30.66, VWAP 30.09 (below VWAP), IEX volume 1.20× its 20-day average. Trend: +6.9% over three months, 87% of the way up its 52-week range, RSI(14) 73, above its 50-day and above its 200-day average.

Intraday chart of GEN on 2026-11-02
Session (intraday)
Three-month daily chart of GEN
Three months (daily)
Revenue (latest FY)
$5.00B
Net income (latest FY)
$973.0M
Cash
$589.0M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Gen Digital Inc filings on SEC EDGAR

NWBI

Northwest Bancshares Inc

15.66+2.7%
FinancialBanks - Regional
3 months−1.9%
52-week range52w low90%high
RSI (14)61
Session
at VWAP 15.621.02× avg vol
Moving averages
above 50dabove 200d
View NWBI chart on TradingView Affiliate
Case study: why NWBI is on this page

Landed at the top of today's combined fundamentals-and-trend screen for this group: reported a net profit in its latest fiscal year; price sits above its 200-day average.

Close 15.66: +2.7% vs previous closeSession (open→close): +1.9%

Session: day range 15.37–15.71, VWAP 15.62 (at VWAP), IEX volume 1.02× its 20-day average. Trend: −1.9% over three months, 90% of the way up its 52-week range, RSI(14) 61, above its 50-day and above its 200-day average.

Intraday chart of NWBI on 2026-11-02
Session (intraday)
Three-month daily chart of NWBI
Three months (daily)
Revenue (latest FY)
n/a
Net income (latest FY)
$126.0M
Cash
$248.5M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Northwest Bancshares Inc filings on SEC EDGAR

Bottom of the screen

SMR

NuScale Power Corp

5.34−4.9%
IndustrialsSpecialty Industrial Machinery
3 months−43.0%
52-week range52w low0%high
RSI (14)32
Session
below VWAP 5.570.83× avg vol
Moving averages
below 50dbelow 200d
View SMR chart on TradingView Affiliate
Case study: why SMR is on this page

Landed at the bottom of today's combined fundamentals-and-trend screen for this group: reported a net loss in its latest fiscal year; annual revenue shrank 15% year over year; price sits below its 200-day average; trading near the bottom of its 52-week range; moved -43.0% over the last three months.

Close 5.34: −4.9% vs previous closeSession (open→close): −7.0%

Session: day range 5.32–5.83, VWAP 5.57 (below VWAP), IEX volume 0.83× its 20-day average. Trend: −43.0% over three months, 0% of the way up its 52-week range, RSI(14) 32, below its 50-day and below its 200-day average.

Intraday chart of SMR on 2026-11-02
Session (intraday)
Three-month daily chart of SMR
Three months (daily)
Revenue (latest FY)
$31.5M
Net income (latest FY)
−$355.8M
Cash
$766.5M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: NuScale Power Corp filings on SEC EDGAR

MLYS

Mineralys Therapeutics Inc

15.51−14.6%
HealthcareBiotechnology
3 months−42.2%
52-week range52w low0%high
RSI (14)24
Session
below VWAP 16.232.46× avg vol
Moving averages
below 50dbelow 200d
View MLYS chart on TradingView Affiliate
Case study: why MLYS is on this page

Landed at the bottom of today's combined fundamentals-and-trend screen for this group: reported a net loss in its latest fiscal year; price sits below its 200-day average; trading near the bottom of its 52-week range; moved -42.2% over the last three months.

Close 15.51: −14.6% vs previous closeSession (open→close): −14.9%

Session: day range 15.43–18.29, VWAP 16.23 (below VWAP), IEX volume 2.46× its 20-day average. Trend: −42.2% over three months, 0% of the way up its 52-week range, RSI(14) 24, below its 50-day and below its 200-day average.

Intraday chart of MLYS on 2026-11-02
Session (intraday)
Three-month daily chart of MLYS
Three months (daily)
Revenue (latest FY)
n/a
Net income (latest FY)
−$154.7M
Cash
$138.3M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Mineralys Therapeutics Inc filings on SEC EDGAR

21matched the screen
21studied in depth
4on this page

Top of the screen

MEDP

Medpace Holdings Inc

647.46−0.7%
HealthcareDiagnostics & Research
3 months+10.1%
52-week range52w low85%high
RSI (14)53
Session
at VWAP 648.960.57× avg vol
Moving averages
above 50dabove 200d
View MEDP chart on TradingView Affiliate
Case study: why MEDP is on this page

Landed at the top of today's combined fundamentals-and-trend screen for this group: reported a net profit in its latest fiscal year; annual revenue grew 20% year over year; price sits above its 200-day average.

Close 647.46: −0.7% vs previous closeSession (open→close): +0.4%

Session: day range 642.00–653.22, VWAP 648.96 (at VWAP), IEX volume 0.57× its 20-day average. Trend: +10.1% over three months, 85% of the way up its 52-week range, RSI(14) 53, above its 50-day and above its 200-day average.

Intraday chart of MEDP on 2026-11-02
Session (intraday)
Three-month daily chart of MEDP
Three months (daily)
Revenue (latest FY)
$2.53B
Net income (latest FY)
$451.1M
Cash
$705.3M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Medpace Holdings Inc filings on SEC EDGAR

MU

Micron Technology Inc

833.42−5.8%
TechnologySemiconductors
3 months−6.7%
52-week range52w low60%high
RSI (14)37
Session
below VWAP 856.651.48× avg vol
Moving averages
below 50dabove 200d
View MU chart on TradingView Affiliate
Case study: why MU is on this page

Landed at the top of today's combined fundamentals-and-trend screen for this group: reported a net profit in its latest fiscal year; annual revenue grew 256% year over year; price sits above its 200-day average.

Close 833.42: −5.8% vs previous closeSession (open→close): −6.4%

Session: day range 829.27–892.06, VWAP 856.65 (below VWAP), IEX volume 1.48× its 20-day average. Trend: −6.7% over three months, 60% of the way up its 52-week range, RSI(14) 37, below its 50-day and above its 200-day average.

Intraday chart of MU on 2026-11-02
Session (intraday)
Three-month daily chart of MU
Three months (daily)
Revenue (latest FY)
$133.19B
Net income (latest FY)
$84.97B
Cash
$38.36B

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Micron Technology Inc filings on SEC EDGAR

Bottom of the screen

UI

Ubiquiti Inc

539.23−4.9%
TechnologyCommunication Equipment
3 months−5.0%
52-week range52w low6%high
RSI (14)36
Session
below VWAP 545.231.02× avg vol
Moving averages
below 50dbelow 200d
View UI chart on TradingView Affiliate
Case study: why UI is on this page

Landed at the bottom of today's combined fundamentals-and-trend screen for this group: reported a net profit in its latest fiscal year; annual revenue grew 27% year over year; price sits below its 200-day average; trading near the bottom of its 52-week range.

Close 539.23: −4.9% vs previous closeSession (open→close): −4.2%

Session: day range 539.21–562.68, VWAP 545.23 (below VWAP), IEX volume 1.02× its 20-day average. Trend: −5.0% over three months, 6% of the way up its 52-week range, RSI(14) 36, below its 50-day and below its 200-day average.

Intraday chart of UI on 2026-11-02
Session (intraday)
Three-month daily chart of UI
Three months (daily)
Revenue (latest FY)
$3.27B
Net income (latest FY)
$960.3M
Cash
$522.6M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Ubiquiti Inc filings on SEC EDGAR

KLAC

KLA Corp

153.10−3.0%
TechnologySemiconductor Equipment & Materials
3 months−20.6%
52-week range52w low0%high
RSI (14)37
Session
below VWAP 156.901.19× avg vol
Moving averages
below 50dbelow 200d
View KLAC chart on TradingView Affiliate
Case study: why KLAC is on this page

Landed at the bottom of today's combined fundamentals-and-trend screen for this group: reported a net profit in its latest fiscal year; annual revenue grew 12% year over year; price sits below its 200-day average; trading near the bottom of its 52-week range; moved -20.6% over the last three months.

Close 153.10: −3.0% vs previous closeSession (open→close): −4.8%

Session: day range 152.78–162.03, VWAP 156.90 (below VWAP), IEX volume 1.19× its 20-day average. Trend: −20.6% over three months, 0% of the way up its 52-week range, RSI(14) 37, below its 50-day and below its 200-day average.

Intraday chart of KLAC on 2026-11-02
Session (intraday)
Three-month daily chart of KLAC
Three months (daily)
Revenue (latest FY)
$13.58B
Net income (latest FY)
$4.83B
Cash
$1.53B

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: KLA Corp filings on SEC EDGAR

The charts use the candlestick, VWAP and moving-average reading taught in our free courses. To pull up any of these tickers yourself, TradingView’s free plan covers it. Affiliate link: we may earn a commission if you subscribe, at no extra cost to you.

Reminder: nothing on this page is investment advice. These names appear because of where they landed in the screen, not because of any view on where the price goes next. Past performance does not indicate future results. See the Disclaimer.